
NeosRx CEO Jeff Dunn, Pharm.D., MBA, explains how 340B claims can disadvantage PBMs because of loss of rebates..
People with overactive bladder, incontinent or not, often think they must tolerate symptoms, but that&s a terrible mistake. Therapy is safe, effective, and uncomplicated.






